NDC 59651-322 – Cephalexin
Cephalexin 125 mg/5mL · Powder, For Suspension · Oral
Product NDC59651-322
Product details
- Brand name
- Cephalexin
- Generic name
- Cephalexin
- Labeler
- Aurobindo Pharma Limited
- Dosage form
- Powder, For Suspension
- Route
- Oral
- Marketing category
- ANDA · ANDA213568
- Marketed since
- June 9, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Cephalosporin Antibacterial
Active ingredients
- Cephalexin 125 mg/5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59651-322-01 | 100 mL in 1 BOTTLE (59651-322-01) | Jun 9, 2026 |
| 59651-322-02 | 200 mL in 1 BOTTLE (59651-322-02) | Jun 9, 2026 |
Other Cephalexin products
- 59651-323 Cephalexin 250 mg/5mL · Powder, For Suspension · Aurobindo Pharma Limited
- 62135-481 Cephalexin 250 mg/5mL · Powder, For Suspension · Chartwell RX, LLC
- 62135-480 Cephalexin 125 mg/5mL · Powder, For Suspension · Chartwell RX, LLC
- 66267-982 Cephalexin 250 mg/5mL · Powder, For Suspension · NuCare Pharmaceuticals,Inc.
- 63187-205 Cephalexin 250 mg/5mL · Powder, For Suspension · Proficient Rx LP
- 0093-4175 Cephalexin 125 mg/5mL · Powder, For Suspension · Teva Pharmaceuticals USA, Inc.
- 0093-4177 Cephalexin 250 mg/5mL · Powder, For Suspension · Teva Pharmaceuticals USA, Inc.
- 50090-3199 Cephalexin 500 mg/1 · Capsule · A-S Medication Solutions
- 50090-0081 Cephalexin 500 mg/1 · Capsule · A-S Medication Solutions
- 50090-3291 Cephalexin 250 mg/1 · Capsule · A-S Medication Solutions
- 50090-3252 Cephalexin 500 mg/1 · Capsule · A-S Medication Solutions
- 50090-4795 Cephalexin 250 mg/5mL · For Suspension · A-S Medication Solutions